FLUZONE, a new high strength influenza vaccine for over-65s, is expected to be added to the National Immunisation Program this year, with Australian Doctor reporting manufacturer Sanofi is ramping up production to ensure availability for the 2018 season.
ADVANCED Pharmacy Australia (AdPha) and the Pharmacy Guild of Australia have called on the Federal Government to immediately extend the eligibility criteria for the new Commonwealth Prac Payments (CPP) to include pharmacy students.
EGO Pharmaceuticals is set to double the production of its therapeutic skincare products following the launch of a $156 million investment in its manufacturing capabilities at Braeside, Melbourne.
PACIFIC Friends of Global Health has welcomed the Australian Government’s renewed five year commitment of $386 million to international vaccination provider Gavi, the Vaccine Alliance, saying it demonstrates Australia’s steadfast leadership in global health.
Notifications
